Navigation Links
Einstein Montefiore lung specialist to receive award for work with 9/11 rescue workers
Date:5/2/2011

May 2, 2011 (BRONX, NY) In honor of his significant clinical care and groundbreaking research with rescue workers who worked at the World Trade Center following the September 11, 2001 terrorists attacks, David Prezant, M.D., will receive the 2011 Public Service Award from the American Thoracic Society (ATS). Dr. Prezant is professor of medicine at Albert Einstein College of Medicine of Yeshiva University and an attending physician in the pulmonary medicine division at Montefiore Medical Center, The University Hospital and Academic Medical Center for Einstein.

David Prezant, M.D.On 9/11, Dr. Prezant was one of the first physicians to respond to the World Trade Center, with responsibility for triaging the injured. From that day on, he treated and monitored the lung health of more than 16,000 rescue workers from the Fire Department of the City of New York (FDNY) who were exposed to World Trade Center dust beginning the largest longitudinal study ever reported on occupational influences on lung function. Through regular assessments of the firefighters and EMS fire department rescue workers, Dr. Prezant evaluated and documented the significant and permanent lung damage that many suffered. His research on World Trade Center Cough Syndrome and the decline of lung function was published in the New England Journal of Medicine in 2002 and 2010.

"David Prezant embodies the spirit of public service that the ATS honors with this award," said Dean Schraufnagel, M.D., President of ATS. "His personal bravery on the scene at the World Trade Center, and his professional courage with documenting the effects of 9/11 exposures on the workers afterwards, are something we should all aspire to. We congratulate him and offer this award in recognition of his extraordinary work."

ATS, a medical association of more than 15,000 members dedicated to preventing and fighting respiratory disease around the globe, gives its Public Service Award each year to individuals who have made contributions in the public health arena related to this mission.

"I am so honored to be presented with this award, which highlights the importance of not just my work, but of the field of pulmonary medicine itself, in terms of its impact on public health," said Dr. Prezant. "The selfless actions of these first responders, rescue and recovery workers helped save countless lives. They deserve anything we can do to help them monitor and regain their health. Hopefully, through the lessons we have learned, similar health consequences can be prevented at future disasters."

This year, in no small part because of the work of Dr. Prezant and his colleagues, President Obama signed legislation to expand and extend funding so that anyone suffering from these exposures first responders, construction workers, volunteers and community residents is eligible to receive necessary healthcare.

Dr. Prezant, who is also the chief medical officer of the FDNY, will accept the award at the ATS's International Conference in Denver on May 15, 2011.


'/>"/>

Contact: Kim Newman
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Related medicine news :

1. Feinstein scientists identify abnormal disease pathway in dystonia
2. Susan Band Horwitz, Ph.D., of Einstein, receives lifetime achievement award in cancer research
3. Einstein-Montefiore researcher will test nanoparticles against pancreatic cancer
4. ALBERT EINSTEIN COLLEGE OF MEDICINE HELPS ADDRESS NEED FOR IMPROVED CANCER CARE IN RURAL AMERICA
5. Feinstein Institute to share $5M US Department of Defense grant
6. Einstein scientist awarded $4 million to develop genetic strategy to combat tuberculosis
7. Einstein awarded NIH grant to study drug-resistant TB
8. NIH awards $10M to Einstein for diabetes research
9. NCI awards $1.7 million to cancer specialist at Childrens Hospital Los Angeles
10. Bone specialists and clinicians from across Europe convene in Valencia, Spain
11. OncologyPRO: Unique portal for cancer specialists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many of ... beholder, according to experts who offered insights and commentary in the current issue of ... full issue, click here . , For the American Society of Clinical Oncology ...
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... their offering. The current ... environment for MedImmune to enter. The US ageing population creates ... drive considerable growth for effective anti-influenza medications. The introduction of ... but development is still in its infancy. ...
Breaking Medicine Technology: